Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by CravenRaven101on Jul 28, 2011 3:38pm
222 Views
Post# 18884603

RE: RE: RE: Seeing the End Game

RE: RE: RE: Seeing the End GameANYONE that relies on an investor's open forum that is free to the public to base investment decisions on... should NOT be handling their own investment decisions let alone be allowed to hold a bank account without the permission of someone who holds power of attorney over them.

ANYONE that believes stockhouse OR any open forum for investors is NOT populated by a certain percentage of ne-erdowells should consider speaking to their health care professional about either increasing or decreasing the therapeutic dosages of their mood stabilziers and or anti-psychotics and or both.

BOILS down to this... with every investment there's winners and loosers, leaders and followers...and within those categories there will always be folks like Germini (aka a whole host of loosers) who are simply incapable of accepting that they are responsible for the decisions they made.

ONC is and always has been in MY books a worthy spec buy at this price... and at any price... provided your money has the time and patience to wait out all the regulatory and corporate hurdles an independent drug developer faces... and lets face it... the dumpsters of investing are filled to the brim with small pharma companies that had a good idea that just were NEVER ever going to be successful for a million reasons...

IS ONC heading for the dumpster? I would wager against it...BUT there are still benchmarks to hit before ONC is in the clear and on the path to riches for all of us...

buy on the lows and de-risk on the highs...

as always it's MY opinion git yer own (from MORE thanONE source)
Bullboard Posts